Ten Years of Experience in the Diagnosis and Treatment of Neonatal Arrhythmias

Use of temporarily placed epicardial atrial wire electrodes for the diagnosis and treatment of cardiac arrhythmias following open-heart surgery

Objective To summarize and investigate the incidence,reason,diagnosis and treatment of postoperative early cardiac arrhythmia after orthotopic liver transplantation(OLT).Method A retrospective study was made for the incidence,dignosis and treatment of cardiac arrhythmia (two weeks after OLT) following OLT from June 2004 to January 2012 in the Beijing You-An Hospital.Results In 500 patients who received OLT,Cardiac arrhythmia developed in 82 patients (16.4％).Among these cardiac arrhythmia,35(7.0 ％) were sick sinus syndrome (including severe sinus bradycardia ),18 (3.6 ％ ) were paroxysmal supraventricular tachycardia,21(4.2 ％) were atrial fibrillation,8(1.6 ％,including 2 patients with torsades de pointes) were ventricular tachycardia and 4 (0.8 ％ )were cardiac arrest.Mortality rate after OLT relate to cardiac arrhythmia was 0.4％ (2 patients).Cardiac arrhythmia was mainly correlated with four factors:(1)whether patient had heart disease before OLT or not(x2 =15.82,P＜0.01),(2)Prolonged QT interval in patients with end-stage liver disease before OLT(x2 =11.00,P＜0.01).Conclusions Cardiac arrhythmia was common complication after OLT,and it can lead to death of recipients.Careful evaluation to recipients before OLT,controlling fluid load after OLT,keeping the balance of the electrolyte,acidity and alkalescence,giving intensive monitor to patients with heart disease before OLT and prolonged QT interval are the key factor to reduce incidence and mortality of cardiac arrhythmia.Application of medication and cardiac pacemaker can prevent cardiovascular accident after OLT. Key words: Liver transplantation; Arrhythmia; Causality

The rapid growth in computational power, sensor technology, and wearable devices has provided a solid foundation for all aspects of cardiac arrhythmia care. Artificial intelligence (AI) has been instrumental in bringing about significant changes in the prevention, risk assessment, diagnosis, and treatment of arrhythmia. This review examines the current state of AI in the diagnosis and treatment of atrial fibrillation, supraventricular arrhythmia, ventricular arrhythmia, hereditary channelopathies, and cardiac pacing. Furthermore, ChatGPT, which has gained attention recently, is addressed in this paper along with its potential applications in the field of arrhythmia. Additionally, the accuracy of arrhythmia diagnosis can be improved by identifying electrode misplacement or erroneous swapping of electrode position using AI. Remote monitoring has expanded greatly due to the emergence of contactless monitoring technology as wearable devices continue to develop and flourish. Parallel advances in AI computing power, ChatGPT, availability of large data sets, and more have greatly expanded applications in arrhythmia diagnosis, risk assessment, and treatment. More precise algorithms based on big data, personalized risk assessment, telemedicine and mobile health, smart hardware and wearables, and the exploration of rare or complex types of arrhythmia are the future direction.

The article analyzes modern methods of diagnosis and treatment of cardiac arrhythmias – atrial fibrillation. The author primarily focuses on the fact that the most important thing for atrial fibrillation is administering an anticoagulant, since failure to follow this recommendation can lead to negative consequences, such as stroke. The article also says on the effectiveness of taking antianrhythmic agents that is proven and recommended. Atrial fibrillation is a kind of pandemic of the 21st century, since, as of 2023, it was found in 43.6 million people worldwide. Particularly, there is a dynamic increase in the frequency of AF after the COVID-19 pandemic. Therefore, updated studies on the follow-up examination and treatment of this arrhythmia are quite relevant.

Relative value of exercise electrocardiography, long-term electrocardiographic monitoring and programmed electrical stimulation of the heart in the treatment of cardiac arrhythmias.

Temporary epicardial wire electrodes in the diagnosis and treatment of arrhythmias after open heart surgery

Evaluation and treatment of cardiac arrhythmias

This article reviews important features for improving the diagnosis of fetal arrhythmias by ultrasound in prenatal cardiac screening and echocardiography. Transient fetal arrhythmias are more common than persistent fetal arrhythmias. However, persistent severe bradycardia and sustained tachycardia may cause fetal hydrops, preterm delivery, and higher perinatal morbidity and mortality. Hence, the diagnosis of these arrhythmias during the routine obstetric ultrasound, before the progression to hydrops, is crucial and represents a challenge that involves a team of specialists and subspecialists on fetal ultrasonography. The images in this review highlight normal cardiac rhythms as well as pathologic cases consistent with premature atrial and ventricular contractions, heart block, supraventricular tachycardia (VT), atrial flutter, and VT. In this review, the details of a variety of arrhythmias in fetuses were provided by M-mode and Doppler ultrasound/echocardiography with high-quality imaging, enhancing diagnostic accuracy. Moreover, an update on the intrauterine management and treatment of many arrhythmias is provided, focusing on improving outcomes to enable planned delivery and perinatal management.

Medical Journal of AustraliaVolume 2, Issue 10 p. 401-402 BOOK REVIEW Diagnosis and Treatment of Cardiac Arrhythmias H. Lipp, H. LippSearch for more papers by this author H. Lipp, H. LippSearch for more papers by this author First published: September 1975 https://doi.org/10.5694/j.1326-5377.1975.tb105906.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume2, Issue10September 1975Pages 401-402 RelatedInformation

Chapter 26 - The Sexually Dimorphic Characteristics of the Pathophysiology and Treatment of Atrial Fibrillation

Cardiac arrhythmias are an important clinical problem since it increases risk of stroke, heart failure, and overall morbidity. Treatment of arrhythmias may include blood thinners, rhythm control, as well as surgical ablation. In this review, we discuss the differences in diagnosis, prognosis and treatment of cardiac arrhythmias in men and women. Further understanding of the gender specific differences of cardiac arrhythmias may be helpful to achieve success and more delivery of more personalized medicine.

Atrial arrhythmias and heart failure frequently coexist. A number of device-based therapies are available for the diagnosis, prevention, and treatment of these arrhythmias. This chapter reviews the clinical impact of atrial and ventricular pacing on atrial arrhythmias, the diagnosis of atrial arrhythmias via device-based data retrieval, the value of alternate site atrial pacing algorithms for prevention of atrial fibrillation, and the treatment of atrial arrhythmias with device-based pacing and defibrillation.Key WordsAtrial fibrillationHeart failurePacemakerDefibrillation

The treatment of many cardiac arrhythmias occurring in the pediatric population is often a perplexing therapeutic problem. An apparent increase in the incidence of these arrhythmias is occurring, probably for several reasons. Physicians have attained a greater awareness of the problem of cardiac arrhythmias in the young; diagnostic capabilities have been improved; and large numbers of patients with congenital cardiac malformations now undergo total surgical correction and experience postoperative cardiac arrhythmias. The pharmacotherapy of cardiac arrhythmias in pediatric patients is determined by multiple factors. Probably foremost among these is the clinical efficacy of a given drug in the hands of an individual pediatrician; that is, his personal experience in antiarrhythmic therapy. Information and experience here are often limited, however, and in many instances the determining factor in selection and method of administration of a drug to the pediatric patient is its use in the treatment of arrhythmias in the adult. Additional requirements for the rational choice of the proper antiarrhythmic agent are (1) an accurate diagnosis of the cardiac arrhythmia; (2) a knowledge of the mechanism for initiation and maintenance of an arrhythmia; (3) an understanding of the electrophysiologic effects, pharmacologic properties and metabolism of the drugs available; and (4) the clinical status of the patient. Any electrolyte imbalance, concomitant drug therapy or organ system dysfunction may alter the absorption and metabolism of the drug. In the past decade there has been a large increment in the literature concerning mechanisms underlying the occurrence of cardiac arrhythmias and their therapy. Our purpose in this review is to familiarize pediatricians with the electrophysiologic basis for arrhythmias, with the mechanisms of action of the commonly used antiarrhythmic drugs, and with their administration, metabolism, excretion and undesirable effects.

There are a large number of arrhythmia patients in China, and the field of interventional therapy for the diagnosis and treatment of arrhythmia has developed rapidly and made remarkable achievements. It is currently in a steady growth trend. In 2021, a total of 99,306 cases of pacemaker, 6547 cases of implantable cardioverter defibrillator, 5333 cases of cardiac resynchronization therapy, and 210,609 cases of catheter ablation were registered in the direct reporting system of arrhythmia interventional therapy information network, all of which increased significantly relative to those in 2020. However, there remains a considerable gap when in comparison with advanced countries. Therefore, there is an urgent need to widely implement and standardize advanced arrhythmia diagnosis and treatment techniques. In the future, it is vital to improve the training and development of arrhythmia physicians and teams, advance graded diagnosis and treatment, and foster international cooperation. In addition, there is a growing demand for increased clinical research to guide practical applications and the promotion of new technologies and devices for arrhythmia diagnosis and treatment.

Several kinds of new technics and methods have been introduced recently for the diagnosis and treatment of arrhythmias. In this report their availability and usefulness will be discussed.